Caveolin‐1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma
- 9 July 2009
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 55 (1) , 10-19
Abstract
Aims: The incidence of mesothelioma is increasing in Europe, Japan and other developing countries. There is difficulty in the accurate diagnosis of mesothelioma and its differentiation from lung adenocarcinoma. Mesothelioma shows a complex immunohistochemical profile. Therefore, the use of a immunohistochemical panel that includes both positive and negative mesothelial markers has become a general rule for its accurate diagnosis. However, they are still not sufficient. The aim was to assess the diagnostic utility of caveolin‐1 (Cav‐1), which is expressed in endothelial cells, alveolar type I pneumocytes and mesothelial cells, as a novel positive marker of mesothelioma.Methods and results: An immunohistochemical study of 80 cases of epithelioid mesothelioma and 80 cases of lung adenocarcinoma was performed for the analysis of the expression of Cav‐1 and other markers. Cav‐1 expression with a membranous and/or cytoplasmic pattern was found in all of the epithelioid mesothelioma. Of these, 42 cases (52.5%) showed Cav‐1 expression in >50% of tumour cells, 34 cases (42.5%) in 6–50% of tumour cells, and four cases (5.0%) in Conclusions: Cav‐1 is a novel immunohistochemical marker for the differentiation of epithelioid mesothelioma from lung adenocarcinoma.Keywords
This publication has 33 references indexed in Scilit:
- Caveolin-1 in tumor progression: the good, the bad and the uglyCancer and Metastasis Reviews, 2008
- Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinomaPathology International, 2007
- Novel marker D2‐40, combined with calretinin, CEA, and TTF‐1Cancer, 2007
- D2-40 and calretinin—a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiationLaboratory Investigation, 2007
- The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvementDiagnostic Cytopathology, 2006
- Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleuraJournal of Clinical Pathology, 2006
- Immunolocalization of Caveolin-1 in Rat and Human MesotheliumJournal of Histochemistry & Cytochemistry, 2004
- Caveolin, Caveolae, and Endothelial Cell FunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Hormonal regulation of caveolae internalization.Journal of Cell Biology, 1995
- Caveolin, a protein component of caveolae membrane coatsCell, 1992